The genetic testing company 23andMe is expanding its offering to make it easier for people to combat type 2 diabetes.
As part of its $199 Health & Ancestry Service test, 23andMe will also screen the user’s for type 2 diabetes, in addition to a variety of other health conditions. The test, however, won’t say for sure whether a person has diabetes or will definitely get it, but the results will provide insight into whether someone is at risk of becoming diabetic.
The company explains that the diabetes risk was pulled out from the analysis of data 23andMe collected from more than 2.5 million customers who opted in to its research. Scientists evaluated the user data and created a system of scoring a person’s likelihood of getting type 2 diabetes based on more than 1,000 genetic factors.
Diabetes affects millions of people across the world. In the U.S., alone, it is estimated that one in three Americans is pre-diabetic and half of Americans will be impacted by diabetes at some point in their lifetimes. The cost to treat diabetes is $327 billion per year, according to the American Diabetes Association.
Type 2 can occur later in life, and can often be prevented or managed with a healthier lifestyle.